Medivation Announces Participation at Upcoming Investor Conferences

Marketwired

SAN FRANCISCO, CA--(Marketwired - Oct 30, 2013) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:

  • David Hung, M.D., president and chief executive officer, will present at the Credit Suisse Healthcare Conference on Wednesday, November 13 at 1:30pm at the Phoenician Hotel in Scottsdale, AZ.
  • David Hung, M.D., president and chief executive officer, will present at the Jefferies 2013 London Healthcare Conference on Wednesday, November 20 at 2:20 pm at the Waldorf Hilton in London.

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contact:

Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Rates

View Comments (0)